Please select molecule type
IgG1
Single Chain
Bispecific
Other IgG
Glycoprotein
Mammalian Gene to GMP – Know your molecule’s development timeline in advance!
As an innovation-led, contract research, development and manufacturing organization, we are always looking at ways to reduce uncertainties in the drug development process for our clients. One of the biggest challenges is knowing the development timeline in advance, in order to plan better for post-production and commercialization activities.
To this end, we have developed a unique tool for Biologics that will help our clients know their molecule’s development timeline with ease. All you need to do is fill in the required details and click ‘Submit’. The tool generates the estimated timeline for progressing your molecule from Gene to GMP in a matter of seconds.
Mammalian Gene to GMP – Know your molecule’s development timeline in advance!
As an innovation-led, contract research, development and manufacturing organization, we are always looking at ways to reduce uncertainties in the drug development process for our clients. One of the biggest challenges is knowing the development timeline in advance, in order to plan better for post-production and commercialization activities.
To this end, we have developed a unique tool for Biologics that will help our clients know their molecule’s development timeline with ease. All you need to do is fill in the required details and click ‘Submit’. The tool generates the estimated timeline for progressing your molecule from Gene to GMP in a matter of seconds.
Thank you for submitting your molecule details. The development timeline estimation is in progress.
Please wait...
Let us discuss your Project
needs
Write to us at bdc@syngeneintl.com
Explore our other services www.syngeneintl.com
Please share your details to email the timeline
Please select molecule type
Please indicate regulatory authority for submission, primary indication of your product and route of administration.
Q1
What is your IND submission target?
Q2
What is the primary indication of product?
Q3
What is the proposed route of administration?
Please indicate your molecule’s current status and information on cell line type, and process and analytical methods.
Q4
Please select current status of information / material available?
Q5
Please select type of cell line used / to be used?
Q6
Are the process and analytical methods in place?
Please share developmental details
Q7
Please select current status of available analytical methods and document
Q8
Can you provide specification / Target product profile for DS / DP?
Q9
Do you have a formulation process?
Please share manufacturing details
Q10
Please select expected batch size for non-GMP material production
Q11